2,2-dimethylpropylboronic acid | CAS:701261-35-0

We serve 2,2-dimethylpropylboronic acid CAS:701261-35-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
 2,2-dimethylpropylboronic acid

Synonyms:
2,2-Dimethylproppylboronic acid
Neopentylboronic acid
 
Molecular Formula: C5H13BO2
Molecular weight:115.96700

Density: 0.905g/cm3
Boiling point: 191.7ºC at 760 mmHg
Melting point: 85-89ºC
Flash point: 69.7ºC
Refractive index: 1.409

Items of Analysis Standard of Analysis Test Results
Appearance White to off-white solid White solid
Purity ≥97% 98.9%
CONCLUSION Conforms to Factory Standard



Contact us for information like 2,2-dimethylpropylboronic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Neopentylboronic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Neopentylboronic acid Use and application,Neopentylboronic acid technical grade,usp/ep/jp grade.


Related News: It is foreseeable that in the future, the capacity and output of bulk APIs in China will decrease, the supply-demand relationship will be balanced, and prices and profits will gradually return to a more reasonable range. The era of low prices in the past will be gone forever. Individual APIs Varieties may even lose their price competitive advantage and move abroad.4-amino-2-anilino-5-(thiophene-2-carbonyl)furan-3-carbonitrile manufacturer Pharmaceutical intermediates and APIs belong to the fine chemical industry.2,4(1H,3H)-Pyrimidinedione, dihydro-6-(1-hydroxyethyl)-1,3-dimethyl- supplier Three more patients have been confirmed infected with coronavirus in South Korea, bringing the country’s total to 15, the South Korean Centers for Disease Control and Prevention (KCDC) announced in a press release.methyl 4-ethyl-2-(4-isopropyl-4-methyl-5-oxo-4,5-dihydro-1H-imidazol-2-yl)benzoate vendor The unit of the British drugmaker, which is challenging HIV drug market leader Gilead Sciences, said it will work with the FDA to determine the next steps for the new drug application.As you can see, a considerable number of staff is involved in the production phase until an API is finally manufactured.